Eli Lilly and its rival Novo Nordisk, which makes the diabetes drug Ozempic ... ahead of approval. States and the FDA inspect the compounding pharmacies that make weight-loss drugs, but they ...
Federal regulators shook up the booming weight loss drug marketplace ... Tirzepatide was first approved by the Food and Drug Administration (FDA) in 2022 and has no generic versions on the market.